Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Although care of patients with heart failure (HF) has improved in the past decade, important
disparities in HF outcomes persist based on race/ethnicity. Age-adjusted HF-related …

During 2017–2019, HDP prevalence among delivery hospitalizations increased from 13.3%
to 15.9%. The highest prevalence was among women aged 35–44 (18.0%) and 45–55 …

Importance Sodium-glucose cotransporter 2 (SGLT2) inhibitors significantly reduce deaths
from cardiovascular conditions, hospitalizations for heart failure, and progression of kidney …

Importance Racial bias is associated with the allocation of advanced heart failure therapies,
heart transplants, and ventricular assist devices. It is unknown whether gender and racial …

Research on racial and ethnic disparities is a common and critical area of investigation in
the health sciences. To best understand such disparities, scientific investigation and …

Background: Racial inequities for patients with heart failure (HF) have been widely
documented. HF patients who receive cardiology care during a hospital admission have …

Background Race influences medical decision making, but its impact on advanced heart
failure therapy allocation is unknown. We sought to determine whether patient race …

Racial and ethnic minorities have the highest incidence, prevalence, and hospitalization
rates from heart failure. In spite of improved therapies and overall survival, the mortality …

Importance While left ventricular assist devices (LVADs) increase survival for patients with
advanced heart failure (HF), racial and sex access and outcome inequities remain and are …